nodes	percent_of_prediction	percent_of_DWPC	metapath
Pomalidomide—TNF—ulcerative colitis	0.237	0.532	CbGaD
Pomalidomide—PTGS2—ulcerative colitis	0.112	0.253	CbGaD
Pomalidomide—ABCB1—ulcerative colitis	0.0956	0.215	CbGaD
Pomalidomide—PTGS2—Olsalazine—ulcerative colitis	0.0732	0.175	CbGbCtD
Pomalidomide—PTGS2—Balsalazide—ulcerative colitis	0.0652	0.156	CbGbCtD
Pomalidomide—PTGS2—Mesalazine—ulcerative colitis	0.0522	0.125	CbGbCtD
Pomalidomide—PTGS2—Sulfasalazine—ulcerative colitis	0.0291	0.0697	CbGbCtD
Pomalidomide—PTGS2—Triamcinolone—ulcerative colitis	0.0291	0.0697	CbGbCtD
Pomalidomide—PTGS2—Betamethasone—ulcerative colitis	0.025	0.0598	CbGbCtD
Pomalidomide—CYP3A4—Budesonide—ulcerative colitis	0.017	0.0407	CbGbCtD
Pomalidomide—PTGS2—Dexamethasone—ulcerative colitis	0.0145	0.0348	CbGbCtD
Pomalidomide—CYP1A2—Nicotine—ulcerative colitis	0.0141	0.0338	CbGbCtD
Pomalidomide—ABCB1—Methylprednisolone—ulcerative colitis	0.0127	0.0303	CbGbCtD
Pomalidomide—ABCB1—Betamethasone—ulcerative colitis	0.00825	0.0197	CbGbCtD
Pomalidomide—ABCB1—Prednisolone—ulcerative colitis	0.00814	0.0195	CbGbCtD
Pomalidomide—ABCB1—Hydrocortisone—ulcerative colitis	0.00771	0.0184	CbGbCtD
Pomalidomide—ABCB1—Prednisone—ulcerative colitis	0.00769	0.0184	CbGbCtD
Pomalidomide—CYP3A4—Methylprednisolone—ulcerative colitis	0.0076	0.0182	CbGbCtD
Pomalidomide—CYP3A4—Nicotine—ulcerative colitis	0.00741	0.0177	CbGbCtD
Pomalidomide—CYP3A4—Cholecalciferol—ulcerative colitis	0.00664	0.0159	CbGbCtD
Pomalidomide—CYP3A4—Triamcinolone—ulcerative colitis	0.00576	0.0138	CbGbCtD
Pomalidomide—CYP3A4—Betamethasone—ulcerative colitis	0.00494	0.0118	CbGbCtD
Pomalidomide—CYP3A4—Prednisolone—ulcerative colitis	0.00488	0.0117	CbGbCtD
Pomalidomide—ABCB1—Dexamethasone—ulcerative colitis	0.0048	0.0115	CbGbCtD
Pomalidomide—CYP3A4—Hydrocortisone—ulcerative colitis	0.00462	0.0111	CbGbCtD
Pomalidomide—CYP3A4—Prednisone—ulcerative colitis	0.0046	0.011	CbGbCtD
Pomalidomide—CYP3A4—Dexamethasone—ulcerative colitis	0.00287	0.00687	CbGbCtD
Pomalidomide—Thalidomide—NFKB1—ulcerative colitis	0.00214	0.464	CrCbGaD
Pomalidomide—Thalidomide—TNF—ulcerative colitis	0.000655	0.142	CrCbGaD
Pomalidomide—PTGS2—Fluocinonide—Budesonide—ulcerative colitis	0.000607	0.247	CbGdCrCtD
Pomalidomide—Thalidomide—PTGS1—ulcerative colitis	0.000544	0.118	CrCbGaD
Pomalidomide—Lenalidomide—PTGS2—ulcerative colitis	0.000519	0.113	CrCbGaD
Pomalidomide—Lenalidomide—ABCB1—ulcerative colitis	0.000441	0.0958	CrCbGaD
Pomalidomide—Thalidomide—PTGS2—ulcerative colitis	0.000311	0.0675	CrCbGaD
Pomalidomide—PTGS2—Fluocinonide—Methylprednisolone—ulcerative colitis	0.000293	0.119	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Betamethasone—ulcerative colitis	0.000288	0.118	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Dexamethasone—ulcerative colitis	0.000288	0.118	CbGdCrCtD
Pomalidomide—PTGS2—Fluocinonide—Triamcinolone—ulcerative colitis	0.000282	0.115	CbGdCrCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—ulcerative colitis	0.000177	0.0721	CbGdCrCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Betamethasone—ulcerative colitis	0.000174	0.0709	CbGdCrCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Dexamethasone—ulcerative colitis	0.000174	0.0709	CbGdCrCtD
Pomalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—ulcerative colitis	0.00017	0.0693	CbGdCrCtD
Pomalidomide—Weight increased—Methylprednisolone—ulcerative colitis	0.000144	0.002	CcSEcCtD
Pomalidomide—Decreased appetite—Budesonide—ulcerative colitis	0.000144	0.00199	CcSEcCtD
Pomalidomide—Skin disorder—Azathioprine—ulcerative colitis	0.000144	0.00199	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Budesonide—ulcerative colitis	0.000143	0.00198	CcSEcCtD
Pomalidomide—Nausea—Nicotine—ulcerative colitis	0.000143	0.00198	CcSEcCtD
Pomalidomide—Fatigue—Budesonide—ulcerative colitis	0.000143	0.00198	CcSEcCtD
Pomalidomide—Pain—Budesonide—ulcerative colitis	0.000142	0.00196	CcSEcCtD
Pomalidomide—Constipation—Budesonide—ulcerative colitis	0.000142	0.00196	CcSEcCtD
Pomalidomide—Infestation NOS—Methylprednisolone—ulcerative colitis	0.000141	0.00196	CcSEcCtD
Pomalidomide—Infestation—Methylprednisolone—ulcerative colitis	0.000141	0.00196	CcSEcCtD
Pomalidomide—Arthralgia—Mesalazine—ulcerative colitis	0.000141	0.00195	CcSEcCtD
Pomalidomide—Anxiety—Mesalazine—ulcerative colitis	0.00014	0.00194	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—ulcerative colitis	0.00014	0.00193	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Triamcinolone—ulcerative colitis	0.000139	0.00192	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Methylprednisolone—ulcerative colitis	0.000139	0.00192	CcSEcCtD
Pomalidomide—Feeling abnormal—Budesonide—ulcerative colitis	0.000137	0.00189	CcSEcCtD
Pomalidomide—Confusional state—Mesalazine—ulcerative colitis	0.000136	0.00188	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000135	0.00187	CcSEcCtD
Pomalidomide—Infection—Mesalazine—ulcerative colitis	0.000134	0.00185	CcSEcCtD
Pomalidomide—Epistaxis—Triamcinolone—ulcerative colitis	0.000134	0.00185	CcSEcCtD
Pomalidomide—Dry skin—Prednisone—ulcerative colitis	0.000133	0.00184	CcSEcCtD
Pomalidomide—Connective tissue disorder—Hydrocortisone—ulcerative colitis	0.000133	0.00184	CcSEcCtD
Pomalidomide—Nervous system disorder—Mesalazine—ulcerative colitis	0.000132	0.00183	CcSEcCtD
Pomalidomide—Hypokalaemia—Prednisone—ulcerative colitis	0.000132	0.00183	CcSEcCtD
Pomalidomide—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000132	0.00183	CcSEcCtD
Pomalidomide—Weight increased—Betamethasone—ulcerative colitis	0.000131	0.00181	CcSEcCtD
Pomalidomide—Weight increased—Dexamethasone—ulcerative colitis	0.000131	0.00181	CcSEcCtD
Pomalidomide—Body temperature increased—Budesonide—ulcerative colitis	0.000131	0.00181	CcSEcCtD
Pomalidomide—Skin disorder—Mesalazine—ulcerative colitis	0.000131	0.00181	CcSEcCtD
Pomalidomide—Hyperhidrosis—Mesalazine—ulcerative colitis	0.00013	0.0018	CcSEcCtD
Pomalidomide—Weight decreased—Dexamethasone—ulcerative colitis	0.00013	0.0018	CcSEcCtD
Pomalidomide—Weight decreased—Betamethasone—ulcerative colitis	0.00013	0.0018	CcSEcCtD
Pomalidomide—Hyperglycaemia—Betamethasone—ulcerative colitis	0.00013	0.0018	CcSEcCtD
Pomalidomide—Hyperglycaemia—Dexamethasone—ulcerative colitis	0.00013	0.0018	CcSEcCtD
Pomalidomide—Alanine aminotransferase increased—Prednisone—ulcerative colitis	0.000128	0.00177	CcSEcCtD
Pomalidomide—Muscular weakness—Prednisone—ulcerative colitis	0.000128	0.00177	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Azathioprine—ulcerative colitis	0.000128	0.00177	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Dexamethasone—ulcerative colitis	0.000126	0.00174	CcSEcCtD
Pomalidomide—Neuropathy peripheral—Betamethasone—ulcerative colitis	0.000126	0.00174	CcSEcCtD
Pomalidomide—Connective tissue disorder—Methylprednisolone—ulcerative colitis	0.000125	0.00172	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000123	0.0017	CcSEcCtD
Pomalidomide—Hypersensitivity—Budesonide—ulcerative colitis	0.000122	0.00169	CcSEcCtD
Pomalidomide—Feeling abnormal—Azathioprine—ulcerative colitis	0.000122	0.00169	CcSEcCtD
Pomalidomide—Insomnia—Mesalazine—ulcerative colitis	0.000122	0.00169	CcSEcCtD
Pomalidomide—Dyspnoea—Mesalazine—ulcerative colitis	0.00012	0.00166	CcSEcCtD
Pomalidomide—Asthenia—Budesonide—ulcerative colitis	0.000119	0.00165	CcSEcCtD
Pomalidomide—Mental disorder—Hydrocortisone—ulcerative colitis	0.000118	0.00164	CcSEcCtD
Pomalidomide—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000118	0.00163	CcSEcCtD
Pomalidomide—Malnutrition—Hydrocortisone—ulcerative colitis	0.000118	0.00163	CcSEcCtD
Pomalidomide—Neutropenia—Prednisone—ulcerative colitis	0.000117	0.00162	CcSEcCtD
Pomalidomide—Pruritus—Budesonide—ulcerative colitis	0.000117	0.00162	CcSEcCtD
Pomalidomide—Decreased appetite—Mesalazine—ulcerative colitis	0.000117	0.00162	CcSEcCtD
Pomalidomide—Body temperature increased—Azathioprine—ulcerative colitis	0.000117	0.00162	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Mesalazine—ulcerative colitis	0.000117	0.00161	CcSEcCtD
Pomalidomide—Fatigue—Mesalazine—ulcerative colitis	0.000116	0.00161	CcSEcCtD
Pomalidomide—Constipation—Mesalazine—ulcerative colitis	0.000115	0.0016	CcSEcCtD
Pomalidomide—Pain—Mesalazine—ulcerative colitis	0.000115	0.0016	CcSEcCtD
Pomalidomide—Angiopathy—Methylprednisolone—ulcerative colitis	0.000115	0.00159	CcSEcCtD
Pomalidomide—Mediastinal disorder—Methylprednisolone—ulcerative colitis	0.000114	0.00158	CcSEcCtD
Pomalidomide—Weight increased—Prednisone—ulcerative colitis	0.000114	0.00158	CcSEcCtD
Pomalidomide—Weight decreased—Prednisone—ulcerative colitis	0.000114	0.00157	CcSEcCtD
Pomalidomide—Diarrhoea—Budesonide—ulcerative colitis	0.000114	0.00157	CcSEcCtD
Pomalidomide—Hyperglycaemia—Prednisone—ulcerative colitis	0.000113	0.00157	CcSEcCtD
Pomalidomide—Feeling abnormal—Mesalazine—ulcerative colitis	0.000111	0.00154	CcSEcCtD
Pomalidomide—Mental disorder—Methylprednisolone—ulcerative colitis	0.000111	0.00154	CcSEcCtD
Pomalidomide—Malnutrition—Methylprednisolone—ulcerative colitis	0.00011	0.00153	CcSEcCtD
Pomalidomide—TNF—Cytokines and Inflammatory Response—IL6—ulcerative colitis	0.00011	0.0019	CbGpPWpGaD
Pomalidomide—Neuropathy peripheral—Prednisone—ulcerative colitis	0.00011	0.00152	CcSEcCtD
Pomalidomide—Dizziness—Budesonide—ulcerative colitis	0.00011	0.00152	CcSEcCtD
Pomalidomide—Hypersensitivity—Azathioprine—ulcerative colitis	0.000109	0.00151	CcSEcCtD
Pomalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—ulcerative colitis	0.000109	0.00189	CbGpPWpGaD
Pomalidomide—Vertigo—Prednisolone—ulcerative colitis	0.000108	0.0015	CcSEcCtD
Pomalidomide—TNF—Selenium Micronutrient Network—ICAM1—ulcerative colitis	0.000107	0.00186	CbGpPWpGaD
Pomalidomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	0.000107	0.00185	CbGpPWpGaD
Pomalidomide—Back pain—Triamcinolone—ulcerative colitis	0.000107	0.00148	CcSEcCtD
Pomalidomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	0.000107	0.00185	CbGpPWpGaD
Pomalidomide—TNF—Angiopoietin receptor Tie2-mediated signaling—NFKB1—ulcerative colitis	0.000107	0.00185	CbGpPWpGaD
Pomalidomide—Body temperature increased—Mesalazine—ulcerative colitis	0.000107	0.00148	CcSEcCtD
Pomalidomide—TNF—Developmental Biology—ARPC2—ulcerative colitis	0.000106	0.00184	CbGpPWpGaD
Pomalidomide—Vertigo—Hydrocortisone—ulcerative colitis	0.000106	0.00146	CcSEcCtD
Pomalidomide—Vomiting—Budesonide—ulcerative colitis	0.000106	0.00146	CcSEcCtD
Pomalidomide—TNF—Vitamin B12 Metabolism—NFKB1—ulcerative colitis	0.000105	0.00182	CbGpPWpGaD
Pomalidomide—Angiopathy—Betamethasone—ulcerative colitis	0.000105	0.00145	CcSEcCtD
Pomalidomide—Angiopathy—Dexamethasone—ulcerative colitis	0.000105	0.00145	CcSEcCtD
Pomalidomide—Rash—Budesonide—ulcerative colitis	0.000105	0.00145	CcSEcCtD
Pomalidomide—Dermatitis—Budesonide—ulcerative colitis	0.000105	0.00145	CcSEcCtD
Pomalidomide—Headache—Budesonide—ulcerative colitis	0.000104	0.00144	CcSEcCtD
Pomalidomide—TNF—Developmental Biology—NR5A2—ulcerative colitis	0.000103	0.00179	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MST1—ulcerative colitis	0.000103	0.00178	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—IFNG—ulcerative colitis	0.000103	0.00178	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IFNG—ulcerative colitis	0.000103	0.00178	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis-related network due to altered Notch3 in ovarian cancer—NFKB1—ulcerative colitis	0.000102	0.00176	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—RELA—ulcerative colitis	0.000101	0.00176	CbGpPWpGaD
Pomalidomide—Diarrhoea—Azathioprine—ulcerative colitis	0.000101	0.0014	CcSEcCtD
Pomalidomide—TNF—TGF-beta Receptor Signaling—NFKB1—ulcerative colitis	0.0001	0.00174	CbGpPWpGaD
Pomalidomide—Anxiety—Hydrocortisone—ulcerative colitis	9.98e-05	0.00138	CcSEcCtD
Pomalidomide—Vertigo—Triamcinolone—ulcerative colitis	9.95e-05	0.00138	CcSEcCtD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—TLR4—ulcerative colitis	9.94e-05	0.00172	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Mesalazine—ulcerative colitis	9.94e-05	0.00138	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—ulcerative colitis	9.94e-05	0.00137	CcSEcCtD
Pomalidomide—Vertigo—Methylprednisolone—ulcerative colitis	9.92e-05	0.00137	CcSEcCtD
Pomalidomide—TNF—Cardiac Hypertrophic Response—NFKB1—ulcerative colitis	9.89e-05	0.00171	CbGpPWpGaD
Pomalidomide—Connective tissue disorder—Prednisone—ulcerative colitis	9.88e-05	0.00137	CcSEcCtD
Pomalidomide—CYP1A2—Estrogen Receptor Pathway—STAT3—ulcerative colitis	9.87e-05	0.00171	CbGpPWpGaD
Pomalidomide—Nausea—Budesonide—ulcerative colitis	9.86e-05	0.00136	CcSEcCtD
Pomalidomide—Dizziness—Azathioprine—ulcerative colitis	9.8e-05	0.00135	CcSEcCtD
Pomalidomide—ABCB1—Allograft Rejection—IL17A—ulcerative colitis	9.76e-05	0.00169	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—CD14—ulcerative colitis	9.73e-05	0.00169	CbGpPWpGaD
Pomalidomide—Asthenia—Mesalazine—ulcerative colitis	9.68e-05	0.00134	CcSEcCtD
Pomalidomide—TNF—Signaling events mediated by HDAC Class I—RELA—ulcerative colitis	9.67e-05	0.00168	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—PPARG—ulcerative colitis	9.67e-05	0.00168	CbGpPWpGaD
Pomalidomide—Cough—Triamcinolone—ulcerative colitis	9.66e-05	0.00134	CcSEcCtD
Pomalidomide—TNF—amb2 Integrin signaling—IL6—ulcerative colitis	9.58e-05	0.00166	CbGpPWpGaD
Pomalidomide—Pruritus—Mesalazine—ulcerative colitis	9.55e-05	0.00132	CcSEcCtD
Pomalidomide—Infection—Hydrocortisone—ulcerative colitis	9.53e-05	0.00132	CcSEcCtD
Pomalidomide—TNF—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	9.51e-05	0.00165	CbGpPWpGaD
Pomalidomide—Hyperhidrosis—Prednisolone—ulcerative colitis	9.5e-05	0.00131	CcSEcCtD
Pomalidomide—Vomiting—Azathioprine—ulcerative colitis	9.42e-05	0.0013	CcSEcCtD
Pomalidomide—Nervous system disorder—Hydrocortisone—ulcerative colitis	9.41e-05	0.0013	CcSEcCtD
Pomalidomide—Arthralgia—Methylprednisolone—ulcerative colitis	9.4e-05	0.0013	CcSEcCtD
Pomalidomide—Anxiety—Methylprednisolone—ulcerative colitis	9.37e-05	0.0013	CcSEcCtD
Pomalidomide—Rash—Azathioprine—ulcerative colitis	9.34e-05	0.00129	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ulcerative colitis	9.34e-05	0.00129	CcSEcCtD
Pomalidomide—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	9.33e-05	0.00162	CbGpPWpGaD
Pomalidomide—Dermatitis—Azathioprine—ulcerative colitis	9.33e-05	0.00129	CcSEcCtD
Pomalidomide—Skin disorder—Hydrocortisone—ulcerative colitis	9.32e-05	0.00129	CcSEcCtD
Pomalidomide—Headache—Azathioprine—ulcerative colitis	9.28e-05	0.00128	CcSEcCtD
Pomalidomide—Hyperhidrosis—Hydrocortisone—ulcerative colitis	9.28e-05	0.00128	CcSEcCtD
Pomalidomide—Diarrhoea—Mesalazine—ulcerative colitis	9.23e-05	0.00128	CcSEcCtD
Pomalidomide—TNF—Folate Metabolism—IL1B—ulcerative colitis	9.17e-05	0.00159	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL2—ulcerative colitis	9.13e-05	0.00158	CbGpPWpGaD
Pomalidomide—TNF—Downstream signaling in naïve CD8+ T cells—IL2—ulcerative colitis	9.13e-05	0.00158	CbGpPWpGaD
Pomalidomide—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—ulcerative colitis	9.12e-05	0.00158	CbGpPWpGaD
Pomalidomide—Angiopathy—Prednisone—ulcerative colitis	9.12e-05	0.00126	CcSEcCtD
Pomalidomide—Confusional state—Methylprednisolone—ulcerative colitis	9.09e-05	0.00126	CcSEcCtD
Pomalidomide—ABCB1—Allograft Rejection—IL12B—ulcerative colitis	9.08e-05	0.00157	CbGpPWpGaD
Pomalidomide—Vertigo—Betamethasone—ulcerative colitis	9.03e-05	0.00125	CcSEcCtD
Pomalidomide—Vertigo—Dexamethasone—ulcerative colitis	9.03e-05	0.00125	CcSEcCtD
Pomalidomide—TNF—TGF-beta Receptor Signaling—STAT3—ulcerative colitis	9.02e-05	0.00156	CbGpPWpGaD
Pomalidomide—PTGS2—Overview of nanoparticle effects—IL6—ulcerative colitis	8.99e-05	0.00156	CbGpPWpGaD
Pomalidomide—Infection—Triamcinolone—ulcerative colitis	8.98e-05	0.00124	CcSEcCtD
Pomalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—RELA—ulcerative colitis	8.96e-05	0.00155	CbGpPWpGaD
Pomalidomide—Infection—Methylprednisolone—ulcerative colitis	8.96e-05	0.00124	CcSEcCtD
Pomalidomide—TNF—Selenium Micronutrient Network—ALB—ulcerative colitis	8.95e-05	0.00155	CbGpPWpGaD
Pomalidomide—Dizziness—Mesalazine—ulcerative colitis	8.92e-05	0.00123	CcSEcCtD
Pomalidomide—TNF—Allograft Rejection—IFNG—ulcerative colitis	8.9e-05	0.00154	CbGpPWpGaD
Pomalidomide—Insomnia—Prednisolone—ulcerative colitis	8.89e-05	0.00123	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—TLR4—ulcerative colitis	8.85e-05	0.00153	CbGpPWpGaD
Pomalidomide—Nervous system disorder—Methylprednisolone—ulcerative colitis	8.84e-05	0.00122	CcSEcCtD
Pomalidomide—Mental disorder—Prednisone—ulcerative colitis	8.8e-05	0.00122	CcSEcCtD
Pomalidomide—Nausea—Azathioprine—ulcerative colitis	8.8e-05	0.00122	CcSEcCtD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL10—ulcerative colitis	8.78e-05	0.00152	CbGpPWpGaD
Pomalidomide—Skin disorder—Methylprednisolone—ulcerative colitis	8.76e-05	0.00121	CcSEcCtD
Pomalidomide—Malnutrition—Prednisone—ulcerative colitis	8.75e-05	0.00121	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	8.74e-05	0.00121	CcSEcCtD
Pomalidomide—Hyperhidrosis—Triamcinolone—ulcerative colitis	8.73e-05	0.00121	CcSEcCtD
Pomalidomide—Hyperhidrosis—Methylprednisolone—ulcerative colitis	8.72e-05	0.00121	CcSEcCtD
Pomalidomide—Insomnia—Hydrocortisone—ulcerative colitis	8.68e-05	0.0012	CcSEcCtD
Pomalidomide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ulcerative colitis	8.68e-05	0.0015	CbGpPWpGaD
Pomalidomide—Vomiting—Mesalazine—ulcerative colitis	8.58e-05	0.00119	CcSEcCtD
Pomalidomide—TNF—Folate Metabolism—NFKB1—ulcerative colitis	8.55e-05	0.00148	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CTLA4—ulcerative colitis	8.53e-05	0.00148	CbGpPWpGaD
Pomalidomide—TNF—IL23-mediated signaling events—IL6—ulcerative colitis	8.53e-05	0.00148	CbGpPWpGaD
Pomalidomide—Anxiety—Dexamethasone—ulcerative colitis	8.52e-05	0.00118	CcSEcCtD
Pomalidomide—Anxiety—Betamethasone—ulcerative colitis	8.52e-05	0.00118	CcSEcCtD
Pomalidomide—Rash—Mesalazine—ulcerative colitis	8.51e-05	0.00118	CcSEcCtD
Pomalidomide—Dermatitis—Mesalazine—ulcerative colitis	8.5e-05	0.00118	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—ICAM1—ulcerative colitis	8.49e-05	0.00147	CbGpPWpGaD
Pomalidomide—Headache—Mesalazine—ulcerative colitis	8.45e-05	0.00117	CcSEcCtD
Pomalidomide—Pain—Prednisolone—ulcerative colitis	8.4e-05	0.00116	CcSEcCtD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	8.37e-05	0.00145	CbGpPWpGaD
Pomalidomide—TNF—TGF-beta Receptor Signaling—TGFB1—ulcerative colitis	8.36e-05	0.00145	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—RELA—ulcerative colitis	8.36e-05	0.00145	CbGpPWpGaD
Pomalidomide—Decreased appetite—Hydrocortisone—ulcerative colitis	8.34e-05	0.00115	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Hydrocortisone—ulcerative colitis	8.28e-05	0.00115	CcSEcCtD
Pomalidomide—TNF—Allograft Rejection—CXCL8—ulcerative colitis	8.28e-05	0.00143	CbGpPWpGaD
Pomalidomide—Fatigue—Hydrocortisone—ulcerative colitis	8.27e-05	0.00114	CcSEcCtD
Pomalidomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ulcerative colitis	8.27e-05	0.00143	CbGpPWpGaD
Pomalidomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—ulcerative colitis	8.25e-05	0.00143	CbGpPWpGaD
Pomalidomide—TNF—Cardiac Hypertrophic Response—TGFB1—ulcerative colitis	8.24e-05	0.00143	CbGpPWpGaD
Pomalidomide—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	8.23e-05	0.00114	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	8.21e-05	0.00114	CcSEcCtD
Pomalidomide—Pain—Hydrocortisone—ulcerative colitis	8.21e-05	0.00113	CcSEcCtD
Pomalidomide—Insomnia—Triamcinolone—ulcerative colitis	8.17e-05	0.00113	CcSEcCtD
Pomalidomide—TNF—Selenium Micronutrient Network—IFNG—ulcerative colitis	8.16e-05	0.00141	CbGpPWpGaD
Pomalidomide—TNF—Signaling events mediated by HDAC Class I—NFKB1—ulcerative colitis	8.16e-05	0.00141	CbGpPWpGaD
Pomalidomide—Insomnia—Methylprednisolone—ulcerative colitis	8.15e-05	0.00113	CcSEcCtD
Pomalidomide—Infection—Betamethasone—ulcerative colitis	8.14e-05	0.00113	CcSEcCtD
Pomalidomide—Infection—Dexamethasone—ulcerative colitis	8.14e-05	0.00113	CcSEcCtD
Pomalidomide—Feeling abnormal—Prednisolone—ulcerative colitis	8.1e-05	0.00112	CcSEcCtD
Pomalidomide—Anaemia—Prednisone—ulcerative colitis	8.09e-05	0.00112	CcSEcCtD
Pomalidomide—Dyspnoea—Triamcinolone—ulcerative colitis	8.06e-05	0.00111	CcSEcCtD
Pomalidomide—TNF—Selenium Micronutrient Network—RELA—ulcerative colitis	8.06e-05	0.0014	CbGpPWpGaD
Pomalidomide—Nervous system disorder—Dexamethasone—ulcerative colitis	8.04e-05	0.00111	CcSEcCtD
Pomalidomide—Nervous system disorder—Betamethasone—ulcerative colitis	8.04e-05	0.00111	CcSEcCtD
Pomalidomide—Thrombocytopenia—Dexamethasone—ulcerative colitis	8.03e-05	0.00111	CcSEcCtD
Pomalidomide—Thrombocytopenia—Betamethasone—ulcerative colitis	8.03e-05	0.00111	CcSEcCtD
Pomalidomide—Nausea—Mesalazine—ulcerative colitis	8.02e-05	0.00111	CcSEcCtD
Pomalidomide—TNF—Allograft Rejection—IL1B—ulcerative colitis	7.94e-05	0.00137	CbGpPWpGaD
Pomalidomide—TNF—Alzheimers Disease—IL1B—ulcerative colitis	7.94e-05	0.00137	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—ulcerative colitis	7.94e-05	0.00137	CbGpPWpGaD
Pomalidomide—Hyperhidrosis—Dexamethasone—ulcerative colitis	7.93e-05	0.0011	CcSEcCtD
Pomalidomide—Hyperhidrosis—Betamethasone—ulcerative colitis	7.93e-05	0.0011	CcSEcCtD
Pomalidomide—TNF—Allograft Rejection—IL2—ulcerative colitis	7.91e-05	0.00137	CbGpPWpGaD
Pomalidomide—Feeling abnormal—Hydrocortisone—ulcerative colitis	7.91e-05	0.00109	CcSEcCtD
Pomalidomide—CYP1A2—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	7.87e-05	0.00136	CbGpPWpGaD
Pomalidomide—Vertigo—Prednisone—ulcerative colitis	7.86e-05	0.00109	CcSEcCtD
Pomalidomide—TNF—Selenium Micronutrient Network—PTGS2—ulcerative colitis	7.83e-05	0.00136	CbGpPWpGaD
Pomalidomide—Fatigue—Triamcinolone—ulcerative colitis	7.79e-05	0.00108	CcSEcCtD
Pomalidomide—Fatigue—Methylprednisolone—ulcerative colitis	7.77e-05	0.00108	CcSEcCtD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—TLR4—ulcerative colitis	7.76e-05	0.00134	CbGpPWpGaD
Pomalidomide—Pain—Triamcinolone—ulcerative colitis	7.73e-05	0.00107	CcSEcCtD
Pomalidomide—TNF—TWEAK Signaling Pathway—IL6—ulcerative colitis	7.71e-05	0.00133	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	7.69e-05	0.00133	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	7.62e-05	0.00132	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—LAMB1—ulcerative colitis	7.61e-05	0.00132	CbGpPWpGaD
Pomalidomide—Body temperature increased—Hydrocortisone—ulcerative colitis	7.59e-05	0.00105	CcSEcCtD
Pomalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—NFKB1—ulcerative colitis	7.56e-05	0.00131	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—HLA-DQA1—ulcerative colitis	7.51e-05	0.0013	CbGpPWpGaD
Pomalidomide—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	7.47e-05	0.00103	CcSEcCtD
Pomalidomide—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	7.47e-05	0.00103	CcSEcCtD
Pomalidomide—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	7.45e-05	0.00129	CbGpPWpGaD
Pomalidomide—Arthralgia—Prednisone—ulcerative colitis	7.45e-05	0.00103	CcSEcCtD
Pomalidomide—Feeling abnormal—Triamcinolone—ulcerative colitis	7.45e-05	0.00103	CcSEcCtD
Pomalidomide—Feeling abnormal—Methylprednisolone—ulcerative colitis	7.43e-05	0.00103	CcSEcCtD
Pomalidomide—Anxiety—Prednisone—ulcerative colitis	7.42e-05	0.00103	CcSEcCtD
Pomalidomide—Insomnia—Dexamethasone—ulcerative colitis	7.42e-05	0.00103	CcSEcCtD
Pomalidomide—Insomnia—Betamethasone—ulcerative colitis	7.42e-05	0.00103	CcSEcCtD
Pomalidomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ulcerative colitis	7.4e-05	0.00102	CcSEcCtD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—ulcerative colitis	7.38e-05	0.00128	CbGpPWpGaD
Pomalidomide—TNF—Signaling events mediated by HDAC Class I—STAT3—ulcerative colitis	7.33e-05	0.00127	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IL1B—ulcerative colitis	7.28e-05	0.00126	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—PPARG—ulcerative colitis	7.28e-05	0.00126	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Prednisolone—ulcerative colitis	7.24e-05	0.001	CcSEcCtD
Pomalidomide—PTGS2—Selenium Micronutrient Network—CRP—ulcerative colitis	7.22e-05	0.00125	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—RELA—ulcerative colitis	7.16e-05	0.00124	CbGpPWpGaD
Pomalidomide—Body temperature increased—Triamcinolone—ulcerative colitis	7.14e-05	0.000988	CcSEcCtD
Pomalidomide—Decreased appetite—Dexamethasone—ulcerative colitis	7.13e-05	0.000986	CcSEcCtD
Pomalidomide—Decreased appetite—Betamethasone—ulcerative colitis	7.13e-05	0.000986	CcSEcCtD
Pomalidomide—Infection—Prednisone—ulcerative colitis	7.09e-05	0.000981	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Dexamethasone—ulcerative colitis	7.08e-05	0.000979	CcSEcCtD
Pomalidomide—Gastrointestinal disorder—Betamethasone—ulcerative colitis	7.08e-05	0.000979	CcSEcCtD
Pomalidomide—Hypersensitivity—Hydrocortisone—ulcerative colitis	7.07e-05	0.000978	CcSEcCtD
Pomalidomide—Fatigue—Betamethasone—ulcerative colitis	7.07e-05	0.000978	CcSEcCtD
Pomalidomide—Fatigue—Dexamethasone—ulcerative colitis	7.07e-05	0.000978	CcSEcCtD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	7.06e-05	0.00122	CbGpPWpGaD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—ulcerative colitis	7.05e-05	0.00122	CbGpPWpGaD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—NFKB1—ulcerative colitis	7.05e-05	0.00122	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—NFKB1—ulcerative colitis	7.05e-05	0.00122	CbGpPWpGaD
Pomalidomide—Pain—Betamethasone—ulcerative colitis	7.01e-05	0.00097	CcSEcCtD
Pomalidomide—Pain—Dexamethasone—ulcerative colitis	7.01e-05	0.00097	CcSEcCtD
Pomalidomide—Nervous system disorder—Prednisone—ulcerative colitis	7e-05	0.000968	CcSEcCtD
Pomalidomide—Skin disorder—Prednisone—ulcerative colitis	6.93e-05	0.000959	CcSEcCtD
Pomalidomide—Hyperhidrosis—Prednisone—ulcerative colitis	6.9e-05	0.000955	CcSEcCtD
Pomalidomide—Asthenia—Hydrocortisone—ulcerative colitis	6.88e-05	0.000952	CcSEcCtD
Pomalidomide—TNF—Selenium Micronutrient Network—NFKB1—ulcerative colitis	6.79e-05	0.00118	CbGpPWpGaD
Pomalidomide—Pruritus—Hydrocortisone—ulcerative colitis	6.79e-05	0.000939	CcSEcCtD
Pomalidomide—Feeling abnormal—Dexamethasone—ulcerative colitis	6.76e-05	0.000934	CcSEcCtD
Pomalidomide—Feeling abnormal—Betamethasone—ulcerative colitis	6.76e-05	0.000934	CcSEcCtD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—CXCL8—ulcerative colitis	6.75e-05	0.00117	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Triamcinolone—ulcerative colitis	6.66e-05	0.000921	CcSEcCtD
Pomalidomide—TNF—Developmental Biology—TCF4—ulcerative colitis	6.65e-05	0.00115	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Methylprednisolone—ulcerative colitis	6.64e-05	0.000919	CcSEcCtD
Pomalidomide—PTGS2—Selenium Micronutrient Network—ICAM1—ulcerative colitis	6.64e-05	0.00115	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL10—ulcerative colitis	6.64e-05	0.00115	CbGpPWpGaD
Pomalidomide—TNF—Vitamin B12 Metabolism—IL6—ulcerative colitis	6.6e-05	0.00114	CbGpPWpGaD
Pomalidomide—Diarrhoea—Hydrocortisone—ulcerative colitis	6.57e-05	0.000908	CcSEcCtD
Pomalidomide—TNF—TNF alpha Signaling Pathway—NFKB1—ulcerative colitis	6.56e-05	0.00114	CbGpPWpGaD
Pomalidomide—Musculoskeletal discomfort—Prednisone—ulcerative colitis	6.5e-05	0.0009	CcSEcCtD
Pomalidomide—Dizziness—Prednisolone—ulcerative colitis	6.5e-05	0.000899	CcSEcCtD
Pomalidomide—Asthenia—Triamcinolone—ulcerative colitis	6.48e-05	0.000897	CcSEcCtD
Pomalidomide—Body temperature increased—Dexamethasone—ulcerative colitis	6.48e-05	0.000896	CcSEcCtD
Pomalidomide—Body temperature increased—Betamethasone—ulcerative colitis	6.48e-05	0.000896	CcSEcCtD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL1B—ulcerative colitis	6.47e-05	0.00112	CbGpPWpGaD
Pomalidomide—Asthenia—Methylprednisolone—ulcerative colitis	6.47e-05	0.000895	CcSEcCtD
Pomalidomide—Insomnia—Prednisone—ulcerative colitis	6.46e-05	0.000893	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—IFNG—ulcerative colitis	6.46e-05	0.00112	CbGpPWpGaD
Pomalidomide—Pruritus—Triamcinolone—ulcerative colitis	6.39e-05	0.000884	CcSEcCtD
Pomalidomide—Pruritus—Methylprednisolone—ulcerative colitis	6.38e-05	0.000882	CcSEcCtD
Pomalidomide—Dizziness—Hydrocortisone—ulcerative colitis	6.35e-05	0.000878	CcSEcCtD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC26A3—ulcerative colitis	6.34e-05	0.0011	CbGpPWpGaD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—ulcerative colitis	6.34e-05	0.0011	CbGpPWpGaD
Pomalidomide—TNF—Transcriptional regulation of white adipocyte differentiation—TGFB1—ulcerative colitis	6.3e-05	0.00109	CbGpPWpGaD
Pomalidomide—Decreased appetite—Prednisone—ulcerative colitis	6.21e-05	0.000858	CcSEcCtD
Pomalidomide—Rash—Prednisolone—ulcerative colitis	6.19e-05	0.000857	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—PTGS2—ulcerative colitis	6.19e-05	0.00107	CbGpPWpGaD
Pomalidomide—Dermatitis—Prednisolone—ulcerative colitis	6.19e-05	0.000856	CcSEcCtD
Pomalidomide—TNF—Allograft Rejection—TGFB1—ulcerative colitis	6.17e-05	0.00107	CbGpPWpGaD
Pomalidomide—Diarrhoea—Methylprednisolone—ulcerative colitis	6.17e-05	0.000853	CcSEcCtD
Pomalidomide—Fatigue—Prednisone—ulcerative colitis	6.16e-05	0.000851	CcSEcCtD
Pomalidomide—Headache—Prednisolone—ulcerative colitis	6.16e-05	0.000851	CcSEcCtD
Pomalidomide—Constipation—Prednisone—ulcerative colitis	6.11e-05	0.000844	CcSEcCtD
Pomalidomide—Vomiting—Hydrocortisone—ulcerative colitis	6.1e-05	0.000844	CcSEcCtD
Pomalidomide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—ulcerative colitis	6.08e-05	0.00105	CbGpPWpGaD
Pomalidomide—Rash—Hydrocortisone—ulcerative colitis	6.05e-05	0.000837	CcSEcCtD
Pomalidomide—Dermatitis—Hydrocortisone—ulcerative colitis	6.04e-05	0.000836	CcSEcCtD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—NFKB1—ulcerative colitis	6.04e-05	0.00105	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—CDH1—ulcerative colitis	6.03e-05	0.00104	CbGpPWpGaD
Pomalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ulcerative colitis	6.02e-05	0.00104	CbGpPWpGaD
Pomalidomide—Headache—Hydrocortisone—ulcerative colitis	6.01e-05	0.000831	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—CXCL8—ulcerative colitis	6e-05	0.00104	CbGpPWpGaD
Pomalidomide—Dizziness—Triamcinolone—ulcerative colitis	5.97e-05	0.000826	CcSEcCtD
Pomalidomide—Dizziness—Methylprednisolone—ulcerative colitis	5.96e-05	0.000825	CcSEcCtD
Pomalidomide—Feeling abnormal—Prednisone—ulcerative colitis	5.88e-05	0.000814	CcSEcCtD
Pomalidomide—Asthenia—Betamethasone—ulcerative colitis	5.88e-05	0.000814	CcSEcCtD
Pomalidomide—Asthenia—Dexamethasone—ulcerative colitis	5.88e-05	0.000814	CcSEcCtD
Pomalidomide—TNF—MicroRNAs in cardiomyocyte hypertrophy—TGFB1—ulcerative colitis	5.87e-05	0.00102	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—TP53—ulcerative colitis	5.86e-05	0.00102	CbGpPWpGaD
Pomalidomide—Nausea—Prednisolone—ulcerative colitis	5.84e-05	0.000807	CcSEcCtD
Pomalidomide—Pruritus—Dexamethasone—ulcerative colitis	5.8e-05	0.000802	CcSEcCtD
Pomalidomide—Pruritus—Betamethasone—ulcerative colitis	5.8e-05	0.000802	CcSEcCtD
Pomalidomide—CYP1A2—Melatonin metabolism and effects—NFKB1—ulcerative colitis	5.78e-05	0.001	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—HNF4A—ulcerative colitis	5.76e-05	0.000998	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL1B—ulcerative colitis	5.76e-05	0.000997	CbGpPWpGaD
Pomalidomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—ulcerative colitis	5.75e-05	0.000996	CbGpPWpGaD
Pomalidomide—Vomiting—Triamcinolone—ulcerative colitis	5.74e-05	0.000795	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—IL2—ulcerative colitis	5.74e-05	0.000994	CbGpPWpGaD
Pomalidomide—Vomiting—Methylprednisolone—ulcerative colitis	5.73e-05	0.000793	CcSEcCtD
Pomalidomide—Nausea—Hydrocortisone—ulcerative colitis	5.7e-05	0.000788	CcSEcCtD
Pomalidomide—Rash—Triamcinolone—ulcerative colitis	5.7e-05	0.000788	CcSEcCtD
Pomalidomide—Dermatitis—Triamcinolone—ulcerative colitis	5.69e-05	0.000787	CcSEcCtD
Pomalidomide—Rash—Methylprednisolone—ulcerative colitis	5.68e-05	0.000786	CcSEcCtD
Pomalidomide—Dermatitis—Methylprednisolone—ulcerative colitis	5.68e-05	0.000785	CcSEcCtD
Pomalidomide—Headache—Triamcinolone—ulcerative colitis	5.66e-05	0.000783	CcSEcCtD
Pomalidomide—Headache—Methylprednisolone—ulcerative colitis	5.65e-05	0.000781	CcSEcCtD
Pomalidomide—Body temperature increased—Prednisone—ulcerative colitis	5.64e-05	0.000781	CcSEcCtD
Pomalidomide—Diarrhoea—Dexamethasone—ulcerative colitis	5.61e-05	0.000776	CcSEcCtD
Pomalidomide—Diarrhoea—Betamethasone—ulcerative colitis	5.61e-05	0.000776	CcSEcCtD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—RELA—ulcerative colitis	5.59e-05	0.000968	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—ALB—ulcerative colitis	5.53e-05	0.000958	CbGpPWpGaD
Pomalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	5.49e-05	0.000951	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TLR4—ulcerative colitis	5.47e-05	0.000948	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—MMP9—ulcerative colitis	5.43e-05	0.00094	CbGpPWpGaD
Pomalidomide—Dizziness—Betamethasone—ulcerative colitis	5.42e-05	0.00075	CcSEcCtD
Pomalidomide—Dizziness—Dexamethasone—ulcerative colitis	5.42e-05	0.00075	CcSEcCtD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—ulcerative colitis	5.4e-05	0.000936	CbGpPWpGaD
Pomalidomide—TNF—Folate Metabolism—IL6—ulcerative colitis	5.37e-05	0.00093	CbGpPWpGaD
Pomalidomide—Nausea—Triamcinolone—ulcerative colitis	5.37e-05	0.000742	CcSEcCtD
Pomalidomide—Nausea—Methylprednisolone—ulcerative colitis	5.35e-05	0.000741	CcSEcCtD
Pomalidomide—ABCB1—Allograft Rejection—HLA-DRB1—ulcerative colitis	5.34e-05	0.000925	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—ulcerative colitis	5.27e-05	0.000912	CbGpPWpGaD
Pomalidomide—Hypersensitivity—Prednisone—ulcerative colitis	5.26e-05	0.000728	CcSEcCtD
Pomalidomide—PTGS2—Spinal Cord Injury—ICAM1—ulcerative colitis	5.25e-05	0.000909	CbGpPWpGaD
Pomalidomide—Vomiting—Betamethasone—ulcerative colitis	5.21e-05	0.000721	CcSEcCtD
Pomalidomide—Vomiting—Dexamethasone—ulcerative colitis	5.21e-05	0.000721	CcSEcCtD
Pomalidomide—Rash—Betamethasone—ulcerative colitis	5.17e-05	0.000715	CcSEcCtD
Pomalidomide—Rash—Dexamethasone—ulcerative colitis	5.17e-05	0.000715	CcSEcCtD
Pomalidomide—Dermatitis—Betamethasone—ulcerative colitis	5.16e-05	0.000714	CcSEcCtD
Pomalidomide—Dermatitis—Dexamethasone—ulcerative colitis	5.16e-05	0.000714	CcSEcCtD
Pomalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—ulcerative colitis	5.14e-05	0.00089	CbGpPWpGaD
Pomalidomide—Headache—Betamethasone—ulcerative colitis	5.14e-05	0.00071	CcSEcCtD
Pomalidomide—Headache—Dexamethasone—ulcerative colitis	5.14e-05	0.00071	CcSEcCtD
Pomalidomide—Asthenia—Prednisone—ulcerative colitis	5.12e-05	0.000708	CcSEcCtD
Pomalidomide—TNF—Alzheimers Disease—TP53—ulcerative colitis	5.08e-05	0.00088	CbGpPWpGaD
Pomalidomide—PTGS2—C-MYB transcription factor network—CD4—ulcerative colitis	5.06e-05	0.000877	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL1B—ulcerative colitis	5.05e-05	0.000875	CbGpPWpGaD
Pomalidomide—Pruritus—Prednisone—ulcerative colitis	5.05e-05	0.000699	CcSEcCtD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IFNG—ulcerative colitis	5.05e-05	0.000874	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—RELA—ulcerative colitis	4.98e-05	0.000863	CbGpPWpGaD
Pomalidomide—Diarrhoea—Prednisone—ulcerative colitis	4.89e-05	0.000676	CcSEcCtD
Pomalidomide—Nausea—Dexamethasone—ulcerative colitis	4.87e-05	0.000674	CcSEcCtD
Pomalidomide—Nausea—Betamethasone—ulcerative colitis	4.87e-05	0.000674	CcSEcCtD
Pomalidomide—TNF—Apoptosis—TP53—ulcerative colitis	4.84e-05	0.000837	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—CXCL8—ulcerative colitis	4.8e-05	0.000832	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—ulcerative colitis	4.8e-05	0.000831	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ulcerative colitis	4.76e-05	0.000824	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—RELA—ulcerative colitis	4.74e-05	0.00082	CbGpPWpGaD
Pomalidomide—Dizziness—Prednisone—ulcerative colitis	4.72e-05	0.000653	CcSEcCtD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—NFKB1—ulcerative colitis	4.71e-05	0.000816	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL1B—ulcerative colitis	4.61e-05	0.000798	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—ulcerative colitis	4.6e-05	0.000797	CbGpPWpGaD
Pomalidomide—Vomiting—Prednisone—ulcerative colitis	4.54e-05	0.000628	CcSEcCtD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL1B—ulcerative colitis	4.5e-05	0.00078	CbGpPWpGaD
Pomalidomide—Rash—Prednisone—ulcerative colitis	4.5e-05	0.000623	CcSEcCtD
Pomalidomide—Dermatitis—Prednisone—ulcerative colitis	4.5e-05	0.000622	CcSEcCtD
Pomalidomide—TNF—Spinal Cord Injury—TGFB1—ulcerative colitis	4.48e-05	0.000775	CbGpPWpGaD
Pomalidomide—Headache—Prednisone—ulcerative colitis	4.47e-05	0.000619	CcSEcCtD
Pomalidomide—TNF—Adipogenesis—STAT3—ulcerative colitis	4.47e-05	0.000774	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—IL1B—ulcerative colitis	4.34e-05	0.000752	CbGpPWpGaD
Pomalidomide—CYP1A2—Arachidonic acid metabolism—PTGS2—ulcerative colitis	4.31e-05	0.000746	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—NFKB1—ulcerative colitis	4.3e-05	0.000744	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—ulcerative colitis	4.28e-05	0.000742	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—ulcerative colitis	4.27e-05	0.000739	CbGpPWpGaD
Pomalidomide—TNF—Selenium Micronutrient Network—IL6—ulcerative colitis	4.26e-05	0.000738	CbGpPWpGaD
Pomalidomide—Nausea—Prednisone—ulcerative colitis	4.24e-05	0.000587	CcSEcCtD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	4.21e-05	0.000729	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—NFKB1—ulcerative colitis	4.2e-05	0.000728	CbGpPWpGaD
Pomalidomide—CYP1A2—Biological oxidations—PTGS1—ulcerative colitis	4.18e-05	0.000724	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—TGFB1—ulcerative colitis	4.14e-05	0.000717	CbGpPWpGaD
Pomalidomide—TNF—TNF alpha Signaling Pathway—IL6—ulcerative colitis	4.12e-05	0.000713	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—NFKB1—ulcerative colitis	4.05e-05	0.000701	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—ulcerative colitis	3.99e-05	0.000692	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IFNG—ulcerative colitis	3.99e-05	0.000692	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IFNG—ulcerative colitis	3.9e-05	0.000676	CbGpPWpGaD
Pomalidomide—TNF—Toll-like Receptor Signaling Pathway—IL6—ulcerative colitis	3.79e-05	0.000656	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC22A4—ulcerative colitis	3.74e-05	0.000647	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC22A5—ulcerative colitis	3.74e-05	0.000647	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—CXCL8—ulcerative colitis	3.71e-05	0.000643	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—TP53—ulcerative colitis	3.68e-05	0.000638	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	3.65e-05	0.000633	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—CXCL8—ulcerative colitis	3.63e-05	0.000628	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CHP1—ulcerative colitis	3.62e-05	0.000626	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL1B—ulcerative colitis	3.56e-05	0.000617	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL2—ulcerative colitis	3.55e-05	0.000614	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL1B—ulcerative colitis	3.48e-05	0.000603	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—IL2—ulcerative colitis	3.47e-05	0.0006	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—TGFB1—ulcerative colitis	3.37e-05	0.000584	CbGpPWpGaD
Pomalidomide—TNF—Spinal Cord Injury—IL6—ulcerative colitis	3.37e-05	0.000584	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—MMP9—ulcerative colitis	3.36e-05	0.000582	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—ulcerative colitis	3.33e-05	0.000576	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—TNF—ulcerative colitis	3.27e-05	0.000566	CbGpPWpGaD
Pomalidomide—CYP3A4—Biological oxidations—PTGS1—ulcerative colitis	3.23e-05	0.000559	CbGpPWpGaD
Pomalidomide—TNF—Adipogenesis—IL6—ulcerative colitis	3.12e-05	0.00054	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—ulcerative colitis	3.11e-05	0.000538	CbGpPWpGaD
Pomalidomide—CYP1A2—Aryl Hydrocarbon Receptor—TNF—ulcerative colitis	3.11e-05	0.000538	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	3.04e-05	0.000527	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CHP1—ulcerative colitis	3.03e-05	0.000524	CbGpPWpGaD
Pomalidomide—TNF—Apoptosis—TP53—ulcerative colitis	2.96e-05	0.000513	CbGpPWpGaD
Pomalidomide—TNF—Regulation of toll-like receptor signaling pathway—IL6—ulcerative colitis	2.96e-05	0.000512	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SEL1L—ulcerative colitis	2.87e-05	0.000497	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	2.84e-05	0.000491	CbGpPWpGaD
Pomalidomide—TNF—MAPK Signaling Pathway—TP53—ulcerative colitis	2.78e-05	0.000481	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TGFB1—ulcerative colitis	2.77e-05	0.000479	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TGFB1—ulcerative colitis	2.7e-05	0.000468	CbGpPWpGaD
Pomalidomide—TNF—SIDS Susceptibility Pathways—IL6—ulcerative colitis	2.7e-05	0.000467	CbGpPWpGaD
Pomalidomide—PTGS2—Selenium Micronutrient Network—IL6—ulcerative colitis	2.64e-05	0.000457	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—DLD—ulcerative colitis	2.61e-05	0.000453	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TNF—ulcerative colitis	2.58e-05	0.000448	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—LTF—ulcerative colitis	2.58e-05	0.000446	CbGpPWpGaD
Pomalidomide—ABCB1—Allograft Rejection—TNF—ulcerative colitis	2.53e-05	0.000437	CbGpPWpGaD
Pomalidomide—TNF—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.51e-05	0.000434	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—PPARG—ulcerative colitis	2.5e-05	0.000433	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	2.33e-05	0.000403	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—TP53—ulcerative colitis	2.28e-05	0.000395	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	2.26e-05	0.000391	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CHP1—ulcerative colitis	2.15e-05	0.000372	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—JAK2—ulcerative colitis	2.09e-05	0.000362	CbGpPWpGaD
Pomalidomide—PTGS2—Spinal Cord Injury—IL6—ulcerative colitis	2.09e-05	0.000361	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—RELA—ulcerative colitis	2.03e-05	0.000351	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.88e-05	0.000326	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—DLD—ulcerative colitis	1.85e-05	0.000321	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	1.85e-05	0.00032	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—SLC11A1—ulcerative colitis	1.84e-05	0.000318	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.76e-05	0.000304	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—MMP9—ulcerative colitis	1.73e-05	0.000299	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CHP1—ulcerative colitis	1.71e-05	0.000297	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—NFKB1—ulcerative colitis	1.71e-05	0.000296	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—MAML2—ulcerative colitis	1.65e-05	0.000286	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—ulcerative colitis	1.61e-05	0.000278	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	1.6e-05	0.000277	CbGpPWpGaD
Pomalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.55e-05	0.000268	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—STAT3—ulcerative colitis	1.54e-05	0.000266	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—DLD—ulcerative colitis	1.48e-05	0.000256	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—TGFB1—ulcerative colitis	1.42e-05	0.000247	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	1.38e-05	0.000239	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CALM3—ulcerative colitis	1.36e-05	0.000235	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	1.33e-05	0.000231	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CHP1—ulcerative colitis	1.32e-05	0.000229	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PTGS1—ulcerative colitis	1.26e-05	0.000219	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	1.25e-05	0.000216	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	1.25e-05	0.000216	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	1.24e-05	0.000215	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—DLD—ulcerative colitis	1.14e-05	0.000198	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—CALM3—ulcerative colitis	1.14e-05	0.000197	CbGpPWpGaD
Pomalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	1.1e-05	0.00019	CbGpPWpGaD
Pomalidomide—TNF—Developmental Biology—IL6—ulcerative colitis	1.07e-05	0.000186	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—ADCY5—ulcerative colitis	9.86e-06	0.000171	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS1—ulcerative colitis	8.96e-06	0.000155	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ABCB1—ulcerative colitis	8.85e-06	0.000153	CbGpPWpGaD
Pomalidomide—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	8.38e-06	0.000145	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ADCY5—ulcerative colitis	8.25e-06	0.000143	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—CALM3—ulcerative colitis	8.07e-06	0.00014	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—ulcerative colitis	7.82e-06	0.000135	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS1—ulcerative colitis	7.15e-06	0.000124	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—ALB—ulcerative colitis	7.03e-06	0.000122	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—CALM3—ulcerative colitis	6.44e-06	0.000112	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—PPARG—ulcerative colitis	6.16e-06	0.000107	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—ulcerative colitis	6.15e-06	0.000107	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—JAK2—ulcerative colitis	6.15e-06	0.000106	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ADCY5—ulcerative colitis	5.85e-06	0.000101	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—CD4—ulcerative colitis	5.83e-06	0.000101	CbGpPWpGaD
Pomalidomide—PTGS2—Metabolism—ALB—ulcerative colitis	5.54e-06	9.59e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS1—ulcerative colitis	5.52e-06	9.56e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ABCB1—ulcerative colitis	5.01e-06	8.67e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—CALM3—ulcerative colitis	4.97e-06	8.61e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ADCY5—ulcerative colitis	4.67e-06	8.09e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—STAT3—ulcerative colitis	4.51e-06	7.81e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PPARG—ulcerative colitis	4.36e-06	7.56e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—TGFB1—ulcerative colitis	4.18e-06	7.24e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—ALB—ulcerative colitis	3.92e-06	6.8e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ABCB1—ulcerative colitis	3.86e-06	6.69e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ADCY5—ulcerative colitis	3.61e-06	6.24e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PPARG—ulcerative colitis	3.48e-06	6.03e-05	CbGpPWpGaD
Pomalidomide—ABCB1—Metabolism—PTGS2—ulcerative colitis	3.43e-06	5.95e-05	CbGpPWpGaD
Pomalidomide—PTGS2—Disease—IL6—ulcerative colitis	3.15e-06	5.46e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—ALB—ulcerative colitis	3.13e-06	5.43e-05	CbGpPWpGaD
Pomalidomide—CYP1A2—Metabolism—PTGS2—ulcerative colitis	2.74e-06	4.75e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PPARG—ulcerative colitis	2.69e-06	4.66e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—ALB—ulcerative colitis	2.42e-06	4.19e-05	CbGpPWpGaD
Pomalidomide—CYP3A4—Metabolism—PTGS2—ulcerative colitis	2.12e-06	3.66e-05	CbGpPWpGaD
